←Back to Expert Scholars
Translational Medicine / 转化医学Thoracic Oncology
Gilberto Lopes
MD, MBA
🏢Sylvester Comprehensive Cancer Center, University of Miami🌐USA
Chief, Division of Medical Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Gilberto Lopes led the global KEYNOTE-042 trial of first-line pembrolizumab in PD-L1 positive advanced NSCLC and is a leader in global cancer access and value-based care. He directs medical oncology at Sylvester Comprehensive Cancer Center.
Share:
🧪Research Fields 研究领域
KEYNOTE-042
global oncology
NSCLC
value in cancer care
health equity
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Gilberto Lopes 的研究动态
Follow Gilberto Lopes's research updates
留下邮箱，当我们发布与 Gilberto Lopes（Sylvester Comprehensive Cancer Center, University of Miami）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment